http://orcid.org/0000-0003-0491-1007
References
- DijkshoornLNemecASeifertHAn increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNat. Rev. Microbiol.20075 939 95110.1038/nrmicro1789
- SantajitSIndrawattanaNMechanisms of antimicrobial resistance in ESKAPE pathogensBiomed. Res. Int.201620162475067487195510.1155/2016/2475067
- WongDClinical and pathophysiological overview of Acinetobacter infections: a century of challengesClin. Microbiol. Rev.201730409447
- DexterCMurrayGLPaulsenITPelegAYCommunity-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesisExpert. Rev. Anti. Infect. Ther.20151356757310.1586/14787210.2015.1025055
- VilaJMartiSSanchez-CespedesJPorins, efflux pumps and multidrug resistance in Acinetobacter baumanniiJ. Antimicrob. Chemother.2007591210121510.1093/jac/dkl509
- AdamsMDComparative genome sequence analysis of multidrug-resistant Acinetobacter baumanniiJ. Bacteriol.200819080538064259323810.1128/JB.00834-08
- RodloffACDowzickyMJAntimicrobial susceptibility among European Gram-negative and Gram-positive isolates collected as part of the tigecycline evaluation and surveillance trial (2004–2014)Chemotherapy20176211110.1159/000445022
- Cruz-MunizMYRepurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infectionsInt. J. Antimicrob. Agents201749889210.1016/j.ijantimicag.2016.08.022
- CirioniOColistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsisDiagn. Microbiol. Infect. Dis.20168639239810.1016/j.diagmicrobio.2016.09.010
- LenhardJRHigh-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumanniiJ. Antimicrob. Chemother.20177215316510.1093/jac/dkw355
- HuebingerRMTargeting bacterial adherence inhibits multidrug-resistant Pseudomonas aeruginosa infection following burn injurySci. Rep.20166517182810.1038/srep39341
- CulpEWrightGDBacterial proteases, untapped antimicrobial drug targetsJ. Antibiot. (Tokyo)20167036637710.1038/ja.2016.138
- MandalRSRibavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulatorsSci. Rep.20166517179010.1038/srep39454
- WongDChaoJDAv-GayYMycobacterium tuberculosis-secreted phosphatases: from pathogenesis to targets for TB drug developmentTrends Microbiol.20132110010910.1016/j.tim.2012.09.002
- CostaTRSecretion systems in Gram-negative bacteria: structural and mechanistic insightsNat. Rev. Microbiol.20151334335910.1038/nrmicro3456
- HachaniAWoodTEFillouxAType VI secretion and anti-host effectorsCurr. Opin. Microbiol.201629819310.1016/j.mib.2015.11.006
- LeimanPGType VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary originProc. Natl. Acad. Sci. USA200910641544159265743510.1073/pnas.0813360106
- ShneiderMMPAAR-repeat proteins sharpen and diversify the type VI secretion system spikeNature2013500350353379257810.1038/nature12453
- Alcoforado DinizJLiuYCCoulthurstSJMolecular weaponry: diverse effectors delivered by the Type VI secretion systemCell. Microbiol.20151717421751483237710.1111/cmi.12532
- HenryRColistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-beta-1,6-N-acetylglucosamineAntimicrob. Agents Chemother.2012565969325609010.1128/AAC.05191-11
- WeberBSGenomic and functional analysis of the type VI secretion system in AcinetobacterPLoS ONE20138e55142355469710.1371/journal.pone.0055142
- CarruthersMDNicholsonPATracyENMunsonRSJr.Acinetobacter baumannii utilizes a type VI secretion system for bacterial competitionPLoS ONE20138e59388360201410.1371/journal.pone.0059388
- RepizoGDDifferential role of the T6SS in Acinetobacter baumannii virulencePLoS ONE201510e0138265458163410.1371/journal.pone.0138265
- KimJMicrobiological features and clinical impact of the type VI secretion system (T6SS) in Acinetobacter baumannii isolates causing bacteremiaVirulence201781378138910.1080/21505594.2017.1323164
- EijkelkampBAStroeherUHHassanKAPaulsenITBrownMHComparative analysis of surface-exposed virulence factors of Acinetobacter baumanniiBMC Genom.20141510.1186/1471-2164-15-1020
- EijkelkampBAH-NS plays a role in expression of Acinetobacter baumannii virulence featuresInfect. Immun.20138125742583369759110.1128/IAI.00065-13
- Muller G. L. et al. Light modulates metabolic pathways and other novel physiological traits in the human pathogen Acinetobacter baumannii. J Bacteriol199, e00011–17 (2017).
- WeberBSLyPMIrwinJNPukatzkiSFeldmanMFA multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumanniiProc. Natl. Acad. Sci. USA201511294429447452276010.1073/pnas.1502966112
- Weber B. S. et al. Genetic dissection of the type VI secretion system in Acinetobacter and identification of a novel peptidoglycan hydrolase, TagX, required for its biogenesis. MBio7, e01253–16 (2016).
- KorndorferIPStructural analysis of the l-alanoyl-d-glutamate endopeptidase domain of Listeria bacteriophage endolysin Ply500 reveals a new member of the LAS peptidase familyActa Crystallogr. D20086464465010.1107/S0907444908007890
- RuizFMCrystal structure of Hcp from Acinetobacter baumannii: a component of the type VI secretion systemPLoS ONE201510e0129691446960710.1371/journal.pone.0129691
- d’EnfertCRyterAPugsleyAPCloning and expression in Escherichia coli of the Klebsiella pneumoniae genes for production, surface localization and secretion of the lipoprotein pullulanaseEMBO J.1987635313538553813
- CianciottoNPType II secretion: a protein secretion system for all seasonsTrends Microbiol.20051358158810.1016/j.tim.2005.09.005
- KorotkovKVSandkvistMHolWGThe type II secretion system: biogenesis, molecular architecture and mechanismNat. Rev. Microbiol.201210336351370571210.1038/nrmicro2762
- DunstanRAAssembly of the type II secretion system such as found in Vibrio cholerae depends on the novel Pilotin AspSPLoS Pathog.20139e1003117354218510.1371/journal.ppat.1003117
- NivaskumarMFranceticOType II secretion system: a magic beanstalk or a protein escalatorBiochim. Biophys. Acta201418431568157710.1016/j.bbamcr.2013.12.020
- Cianciotto N. P., White R. C. Expanding role of Type II secretion in bacterial pathogenesis and beyond. Infect Immun85, e00014–17 (2017).
- ParcheSGeissdorferWHillenWIdentification and characterization of xcpR encoding a subunit of the general secretory pathway necessary for dodecane degradation in Acinetobacter calcoaceticus ADP1J. Bacteriol.19971794631463417930310.1128/jb.179.14.4631-4634.1997
- JohnsonTLWaackUSmithSMobleyHSandkvistMAcinetobacter baumannii is dependent on the type II secretion system and its substrate LipA for lipid utilization and in vivo fitnessJ. Bacteriol.201519871171910.1128/JB.00622-15
- OgiermanMACharacterization of the Vibrio cholerae El Tor lipase operon lipAB and a protease gene downstream of the hly regionJ. Bacteriol.19971797072708017964910.1128/jb.179.22.7072-7080.1997
- HardingCMKinsellaRLPalmerLDSkaarEPFeldmanMFMedically relevant Acinetobacter species require a type II secretion system and specific membrane-associated chaperones for the export of multiple substrates and full virulencePLoS Pathog.201612e1005391471306410.1371/journal.ppat.1005391
- ElhosseinyNMEl-TayebOMYassinASLorySAttiaASThe secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonizationInt. J. Med. Microbiol.201630663364110.1016/j.ijmm.2016.09.006
- WaackUTargeting the type II secretion system: development, optimization, and validation of a high-throughput screen for the identification of small molecule inhibitorsFront Cell Infect. Microbiol.20177380558131410.3389/fcimb.2017.00380
- HuaXColistin resistance in Acinetobacter baumannii MDR-ZJ06 revealed by a multiomics approachFront Cell Infect. Microbiol.2017745531997110.3389/fcimb.2017.00045
- Wright M. S., Jacobs M. R., Bonomo R. A., Adams M. D. Transcriptome remodeling of Acinetobacter baumannii during infection and treatment. MBio8, e02193–16 (2017).
- ThomasSHollandIBSchmittLThe Type 1 secretion pathway—the hemolysin system and beyondBiochim. Biophys. Acta201418431629164110.1016/j.bbamcr.2013.09.017
- BielaszewskaMAldickTBauwensAKarchHHemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulenceInt. J. Med. Microbiol.201430452152910.1016/j.ijmm.2014.05.005
- StanleyPKoronakisVHughesCAcylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin functionMicrobiol. Mol. Biol. Rev.19986230933398917
- LadantDUllmannABordatella pertussis adenylate cyclase: a toxin with multiple talentsTrends Microbiol.1999717217610.1016/S0966-842X(99)01468-7
- SatchellKJStructure and function of MARTX toxins and other large repetitive RTX proteinsAnnu. Rev. Microbiol.201165719010.1146/annurev-micro-090110-102943
- BoydCDStructural features of the Pseudomonas fluorescens biofilm adhesin LapA required for LapG-dependent cleavage, biofilm formation, and cell surface localizationJ. Bacteriol.201419627752788413567510.1128/JB.01629-14
- BarlagBHenselMThe giant adhesin SiiE of Salmonella entericaMolecules2015201134115010.3390/molecules20011134
- HardingCMPathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systemsJ. Biol. Chem.20172929075908710.1074/jbc.M117.781575
- AziziOMolecular analysis and expression of bap gene in biofilm-forming multi-drug-resistant Acinetobacter baumanniiRep. Biochem Mol. Biol.2016562725214686
- EijkelkampBAHassanKAPaulsenITBrownMHInvestigation of the human pathogen Acinetobacter baumannii under iron limiting conditionsBMC Genom.20111210.1186/1471-2164-12-126
- BinetRWandersmanCCloning of the Serratia marcescens hasF gene encoding the Has ABC exporter outer membrane component: a TolC analogueMol. Microbiol.19962226527310.1046/j.1365-2958.1996.00103.x
- BardbariAMCorrelation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolatesMicrob. Pathog.201710812212810.1016/j.micpath.2017.04.039
- SelasiGNDifferences in biofilm mass, expression of biofilm-associated genes, and resistance to desiccation between epidemic and sporadic clones of carbapenem-resistant Acinetobacter baumannii sequence Type 191PLoS ONE201611e0162576502132210.1371/journal.pone.0162576
- JoseJJahnigFMeyerTFCommon structural features of IgA1 protease-like outer membrane protein autotransportersMol. Microbiol.19951837838010.1111/j.1365-2958.1995.mmi_18020378.x
- MartoglioBDobbersteinBSignal sequences: more than just greasy peptidesTrends Cell. Biol.1998841041510.1016/S0962-8924(98)01360-9
- OliverDCHuangGNodelEPleasanceSFernandezRCA conserved region within the Bordetella pertussis autotransporter BrkA is necessary for folding of its passenger domainMol. Microbiol.2003471367138310.1046/j.1365-2958.2003.03377.x
- PohlnerJHalterRBeyreutherKMeyerTFGene structure and extracellular secretion of Neisseria gonorrhoeae IgA proteaseNature198732545846210.1038/325458a0
- PoulsenKBrandtJHjorthJPThogersenHCKilianMCloning and sequencing of the immunoglobulin A1 protease gene (iga) of Haemophilus influenzae serotype bInfect. Immun.19895730973105260775
- BenzISchmidtMAAIDA-I, the adhesin involved in diffuse adherence of the diarrhoeagenic Escherichia coli strain 2787 (O126:H27), is synthesized via a precursor moleculeMol. Microbiol.199261539154610.1111/j.1365-2958.1992.tb00875.x
- ElderKDHarvillETStrain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tractInfect. Immun.2004725919592451757510.1128/IAI.72.10.5919-5924.2004
- AttiaASRamSRicePAHansenEJBinding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascadeInfect. Immun.20067415971611141866610.1128/IAI.74.3.1597-1611.2006
- BentancorLVCamacho-PeiroABozkurt-GuzelCPierGBMaira-LitranTIdentification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumanniiJ. Bacteriol.201219439503960341651010.1128/JB.06769-11
- BentancorLVEvaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infectionsInfect. Immun.20128033813388345756710.1128/IAI.06096-11
- IshikawaMYoshimotoSHayashiAKanieJHoriKDiscovery of a novel periplasmic protein that forms a complex with a trimeric autotransporter adhesin and peptidoglycanMol. Microbiol.201610139441010.1111/mmi.13398
- KoiwaiKHartmannMDLinkeDLupasANHoriKStructural basis for toughness and flexibility in the C-terminal passenger domain of an Acinetobacter trimeric autotransporter adhesinJ. Biol. Chem.20162913705372410.1074/jbc.M115.701698
- Jacob-DubuissonFLochtCAntoineRTwo-partner secretion in Gram-negative bacteria: a thrifty, specific pathway for large virulence proteinsMol. Microbiol.20014030631310.1046/j.1365-2958.2001.02278.x
- SalachaRThe Pseudomonas aeruginosa patatin-like protein PlpD is the archetype of a novel Type V secretion systemEnviron. Microbiol.20101214981512
- LeoJCOberhettingerPSchutzMLinkeDThe inverse autotransporter family: intimin, invasin and related proteinsInt. J. Med. Microbiol.201530527628210.1016/j.ijmm.2014.12.011
- ThanassiDGStathopoulosCKarkalALiHProtein secretion in the absence of ATP: the autotransporter, two-partner secretion and chaperone/usher pathways of Gram-negative bacteria (review)Mol. Membr. Biol.200522637210.1080/09687860500063290
- PerezAThe FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strainVirulence20168959974562624110.1080/21505594.2016.1262313
- ZhangDIyerLMAravindLA novel immunity system for bacterial nucleic acid degrading toxins and its recruitment in various eukaryotic and DNA viral systemsNucleic Acids Res.20113945324552311357010.1093/nar/gkr036
- BeckCMCdiA effectors from uropathogenic Escherichia coli use heterotrimeric osmoporins as receptors to recognize target bacteriaPLoS Pathog.201612e1005925505673410.1371/journal.ppat.1005925
- Ruhe Z. C. et al. CdiA effectors use modular receptor-binding domains to recognize target bacteria. MBio8, e00290–17 (2017).
- IaconoMWhole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II groupAntimicrob. Agents Chemother.20085226162625244389810.1128/AAC.01643-07
- LiuCCKuoHYTangCYChangKCLiouMLPrevalence and mapping of a plasmid encoding a type IV secretion system in Acinetobacter baumanniiGenomics201410421522310.1016/j.ygeno.2014.07.011
- MoonDCAcinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesiclesJ. Microbiol.20125015516010.1007/s12275-012-1589-4
- JinJSAcinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesiclesPLoS ONE20116e17027304617510.1371/journal.pone.0017027
- AlanizRCDeatherageBLLaraJCCooksonBTMembrane vesicles are immunogenic facsimiles of Salmonella Typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivoJ. Immunol.20071797692770110.4049/jimmunol.179.11.7692
- FioccaRRelease of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epitheliumJ. Pathol.199918822022610.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C
- SoleMXanthomonas campestris pv. vesicatoria secretes proteases and xylanases via the Xps type II secretion system and outer membrane vesiclesJ. Bacteriol.201519728792893452403010.1128/JB.00322-15
- MendezJAExtracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumanniiJ. Proteome Res.2012115678569410.1021/pr300496c
- LiZTOuter membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristicsMicrob. Pathog.201581465210.1016/j.micpath.2015.03.009
- JunSHAcinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteinsPLoS ONE20138e71751374374410.1371/journal.pone.0071751
- KuoHYFunctional characterization of Acinetobacter baumannii lacking the RNA chaperone HfqFront. Microbiol.201782068566373310.3389/fmicb.2017.02068
- RumboCHorizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumanniiAntimicrob. Agents Chemother.20115530843090312245810.1128/AAC.00929-10
- LiaoYTAcinetobacter baumannii extracellular OXA-58 is primarily and selectively released via outer membrane vesicles after Sec-dependent periplasmic translocationAntimicrob. Agents Chemother.20155973467354464924610.1128/AAC.01343-15
- ChatterjeeSMondalAMitraSBasuSAcinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesiclesJ. Antimicrob. Chemother.2017722201220710.1093/jac/dkx131
- FulsundarSGene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculationAppl. Environ. Microbiol.20148034693483401886210.1128/AEM.04248-13
- SantosSOuter membrane vesicles (OMV) production of Neisseria meningitidis serogroup B in batch processVaccine2012306064606910.1016/j.vaccine.2012.07.052
- LeitnerDRA combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesiclesFront. Microbiol.20156823453125010.3389/fmicb.2015.00823
- McConnellMJRumboCBouGPachonJOuter membrane vesicles as an acellular vaccine against Acinetobacter baumanniiVaccine2011295705571010.1016/j.vaccine.2011.06.001
- HuangWImmunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis modelsPLoS ONE20149e100727406735410.1371/journal.pone.0100727
- HuangWEmploying Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infectionSci. Rep.20166511095810.1038/srep37242
- BaronCCoombesBTargeting bacterial secretion systems: benefits of disarmament in the microcosmInfect. Disord. Drug Targets20077192710.2174/187152607780090685
- CambergJLSynergistic stimulation of EpsE ATP hydrolysis by EpsL and acidic phospholipidsEMBO J.200726192710.1038/sj.emboj.7601481
- HilleringmannMInhibitors of Helicobacter pylori ATPase Caga block CagA transport and cag virulenceMicrobiology20061522919293010.1099/mic.0.28984-0
- SunKScreening for inhibition of Vibrio cholerae VipA–VipB interaction identifies small-molecule compounds active against type VI secretionAntimicrob. Agents Chemother.20145841234130406851310.1128/AAC.02819-13
- NguyenVSInhibition of type VI secretion by an anti-TssM llama nanobodyPLoS ONE201510e0122187437492110.1371/journal.pone.0122187
- KoraimannGLytic transglycosylases in macromolecular transport systems of Gram-negative bacteriaCell. Mol. Life Sci.2003602371238810.1007/s00018-003-3056-1
- RohdeMPulsJBuhrdorfRFischerWHaasRA novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion systemMol. Microbiol.20034921923410.1046/j.1365-2958.2003.03549.x
- MoirDTDevelopment and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomalleiJ. Biomol. Screen.201116694705319554110.1177/1087057111408605
- HungDTShakhnovichEAPiersonEMekalanosJJSmall-molecule inhibitor of Vibrio cholerae virulence and intestinal colonizationScience200531067067410.1126/science.1116739
- WeberBSKinsellaRLHardingCMFeldmanMFThe secrets of Acinetobacter secretionTrends Microbiol.20172553254510.1016/j.tim.2017.01.005